NAD+ IV Therapy

The NAD+ IV Therapy at RE:BERRY Clinic delivers nicotinamide adenine dinucleotide directly into the bloodstream through a controlled intravenous infusion. NAD+ is a coenzyme found in every living cell, where it plays essential roles in redox reactions that drive mitochondrial energy production (as a carrier of electrons in the electron transport chain), DNA repair mechanisms (as a substrate for PARP enzymes), and epigenetic regulation (as a substrate for…

Research has documented that NAD+ levels decline with age across multiple tissues, and this decline is associated with reduced mitochondrial function, impaired DNA repair capacity, and altered gene expression patterns. The longevity research community has identified NAD+ replenishment as one of the more promising intervention targets, which has driven interest in both oral precursors (NMN, NR) and direct IV NAD+ administration.

Intravenous delivery offers a pharmacokinetic advantage over oral precursors because it bypasses the multi-step enzymatic conversion pathway that NMN and NR must traverse to become NAD+ inside cells. While the body can synthesise NAD+ from these precursors, the conversion efficiency varies between individuals and is influenced by age, liver function, and competing metabolic demands. IV NAD+ provides the finished molecule directly.